Fernando Reyes Benítez

Title: Innovations of Fernando Reyes Benítez in Genetic Engineering

Introduction

Fernando Reyes Benítez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of genetic engineering, particularly through his innovative work on safracin biosynthesis. His research has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Fernando Reyes Benítez holds a patent for a gene cluster involved in safracin biosynthesis. This patent, which includes a nucleic acid sequence, discloses open reading frames that encode polypeptides sufficient to direct the synthesis of a safracin molecule. The patent also covers variants or portions of the nucleic acid sequence, including specific genes such as sacA, sacB, sacC, sacD, sacE, sacF, sacG, sacH, sacI, sacJ, orf1, orf2, orf3, and orf4. He has 1 patent to his name.

Career Highlights

Fernando Reyes Benítez is associated with Pharma Mar, S.A., a company known for its focus on biotechnology and pharmaceuticals. His work at Pharma Mar has allowed him to explore innovative solutions in the field of genetic engineering.

Collaborations

Throughout his career, Fernando has collaborated with several professionals, including Ana Velasco Iglesias and Fernando De La Calle. These collaborations have contributed to the advancement of his research and the development of new technologies.

Conclusion

Fernando Reyes Benítez is a prominent figure in the field of genetic engineering, with a focus on safracin biosynthesis. His innovative patent and collaborations highlight his contributions to biotechnology. His work continues to influence the industry and pave the way for future advancements.